Sfoglia per RIVISTA
OPEN FORUM INFECTIOUS DISEASES
Collezione ASL Città di Torino

  

Items : 4

The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study. in Open forum infectious diseases / Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov.

2021
ASL Città di Torino

Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M;

Factors Associated With Weight Gain in People Treated With Dolutegravir. in Open forum infectious diseases / Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun.

2020
AOU Alessandria
ASL Città di Torino

Dentone C; Vichi F; Maggi P; Bolla C; Cascio A; Valsecchi L; Martinelli CV; Conti F; Calza L; Celesia BM; Pagnucco L; Pellicanò GF; Madeddu G; De Socio GV; Menzaghi B; Squillace N; Orofino G; Ricci E; Bonfanti P; Taramasso L; Angioni G; Mastroianni A; Falasca K; Cenderello G; Di Biagio A;

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible. in Open forum infectious diseases / Open Forum Infect Dis. 2018 Dec 10;6(1):ofy332. doi: 10.1093/ofid/ofy332. eCollection 2019 Jan.

2019
ASL Città di Torino

Pena MJ; Chueca N; D'Avolio A; Zarzalejos JM; Garcia F;

Weight Gain: A Possible Side Effect of All Antiretrovirals. in Open forum infectious diseases / Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239. doi: 10.1093/ofid/ofx239. eCollection 2017 Fall.

2017
ASL Città di Torino

Taramasso L; Ricci E; Menzaghi B; Orofino G; Passerini S; Madeddu G; Martinelli CV; De Socio GV; Squillace N; Rusconi S; Bonfanti P; Di Biagio A;